Human parainfluenza virus: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 22: | Line 22: | ||
**[[Nucleoprotein|nucleoprotein]] | **[[Nucleoprotein|nucleoprotein]] | ||
**[[Phosphoprotein|phosphoprotein]] | **[[Phosphoprotein|phosphoprotein]] | ||
**[[RNA | **[[RNA polymerase|large protein]] | ||
==References== | ==References== | ||
Revision as of 15:55, 27 January 2016
|
Croup Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Human parainfluenza virus On the Web |
|
American Roentgen Ray Society Images of Human parainfluenza virus |
|
Risk calculators and risk factors for Human parainfluenza virus |
| Human parainfluenza virus | ||||||
|---|---|---|---|---|---|---|
 A Transmission Electron Micrograph (TEM) depicting parainfluenza virions, and free filamentous nucleocapsid material.
| ||||||
| Virus classification | ||||||
|
This page is about microbiologic aspects of the organism(s). For clinical aspects of the disease, see Croup.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Microbiological Characteristics
- Human parainfluenza viruses (HPIVs) are a group of four serotypes of enveloped, single stranded negative sense RNA viruses.[1]
- The human parainfluenza virus genome consists of approximately 15,000 nucleotides used to encode the following six structural proteins:.[2]